|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.52 USD | +0.52% |
|
-2.32% | +11.67% |
| 02-13 | Biogen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:30 AM | |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 16.55x | 1.42x | 0.47x | 3.06x | 8.89x | 9.84x | -.--% | 28.84B | ||
| 20.33x | 2.41x | -4.28x | 4.71x | 13.35x | 14.46x | 0.49% | 82.42B | ||
| 44.79x | 4.94x | 3.98x | 7.03x | 22.23x | 30.43x | 0.51% | 63.02B | ||
| 51.52x | 6.93x | 1.23x | 13.6x | 29.17x | 36.53x | -.--% | 54.86B | ||
| 37x | 2.63x | -0.69x | 3.8x | 10.99x | 12.48x | 2.76% | 51.1B | ||
| 15.89x | 2.74x | -21.32x | 2.61x | 8.26x | 7.76x | -.--% | 20.12B | ||
| 80.23x | 7.83x | -0.05x | 9.43x | 98.54x | 92.95x | -.--% | 19.67B | ||
| -5.35x | 1.92x | 0.36x | 6.21x | -3.73x | -3.53x | -.--% | 16.5B | ||
| 685.93x | 3.54x | -7.24x | 5.33x | 13.63x | 43x | -.--% | 15.76B | ||
| -21.88x | -7.14x | -1.13x | 31.6x | -31.65x | -31.23x | -.--% | 14.5B | ||
| 291.45x | 57.47x | 22.95x | 97.86x | 178.17x | 184.28x | - | 14.16B | ||
| 24.11x | - | 1.95x | 3.22x | 16.55x | 16.27x | -.--% | 11.5B | ||
| -16.27x | - | -0.3x | 585.65x | -15.96x | -16.18x | -.--% | 10.98B | ||
| -47.89x | 198.62x | 1.3x | 14.16x | -56.91x | -52.73x | -.--% | 9.14B | ||
| 40.53x | - | 0.32x | 19.37x | 45.57x | 46.62x | -.--% | 8.02B | ||
| 17.59x | 1.17x | 0.1x | 2.06x | 8.55x | 11.37x | 1.47% | 7.91B | ||
| 5.28x | 2.05x | 0.01x | 2.27x | 3.38x | 3.43x | 3.83% | 7.48B | ||
| -222.12x | - | 0.68x | - | - | - | -.--% | 7.35B | ||
| 20.8x | 1.23x | -2.29x | - | - | - | 1.28% | 5.97B | ||
| -12.66x | 1.4x | 0.05x | 3.86x | -25.79x | -26.28x | -.--% | 5.86B | ||
| Average | 51.29x | 18.07x | -0.19x | 45.32x | 17.96x | 21.08x | 0.54% | 22.76B | |
| Weighted average by Cap. | 54.28x | 9.41x | -0.57x | 24.75x | 20.47x | 24.12x | 0.59% |
- Stock Market
- Equities
- BIIB Stock
- Sector Biogen Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















